<p>Pooled incidence of YMDD mutation among CHB patients untreated with antiviral drugs in each region.</p
<p>Individual HBV DNA level of the 3 patients with persist detectable DNA by RealT<i>ime</i>, but un...
Idue where variability was found in ARV-naïve patients. (N): number of samples from naïve patients h...
We sought to examine the role of hepatitis B virus (HBV) genotypes in virological breakthroughs and ...
Several recent reports have demonstrated that tyrosine (Y)-methionine (M)-aspartic acid (D)-aspartic...
<p>Difference in the incidence of YMDD mutation between patients with HBV genotype B and genotype C....
<p>Difference in the incidence of YMDD mutation between lamivudine-treated patients and untreated pa...
BACKGROUND/AIMS: The emergence of a YMDD mutant resistant to lamivudine therapy has been reported in...
Background and Aim: In hepatitis B Virus, one of major problem associate lamivudine therapy is the e...
<p>(A) Genotype distributions of 13 patients with genotype shift observed by clonal sequencing showe...
OBJECTIVE: This study aimed to determine the natural prevalence of variants of tyrosine-methionine-a...
<p>*Among the 14 “difficult-to-treat” CHB cases, only one did not express an rtL269I mutation</p><p>...
<p>Difference in the incidence of YMDD mutation between HBeAg positive and HBeAg negative patients.<...
<p>Mutation frequency (%): the ratio of total mutant clones to total aligned coverage at each nucleo...
<p>Prevalence of Precore, Core and Surface region mutations in HBV isolated among different clinical...
AbstractObjectiveThis study aimed to determine the natural prevalence of variants of tyrosinemethion...
<p>Individual HBV DNA level of the 3 patients with persist detectable DNA by RealT<i>ime</i>, but un...
Idue where variability was found in ARV-naïve patients. (N): number of samples from naïve patients h...
We sought to examine the role of hepatitis B virus (HBV) genotypes in virological breakthroughs and ...
Several recent reports have demonstrated that tyrosine (Y)-methionine (M)-aspartic acid (D)-aspartic...
<p>Difference in the incidence of YMDD mutation between patients with HBV genotype B and genotype C....
<p>Difference in the incidence of YMDD mutation between lamivudine-treated patients and untreated pa...
BACKGROUND/AIMS: The emergence of a YMDD mutant resistant to lamivudine therapy has been reported in...
Background and Aim: In hepatitis B Virus, one of major problem associate lamivudine therapy is the e...
<p>(A) Genotype distributions of 13 patients with genotype shift observed by clonal sequencing showe...
OBJECTIVE: This study aimed to determine the natural prevalence of variants of tyrosine-methionine-a...
<p>*Among the 14 “difficult-to-treat” CHB cases, only one did not express an rtL269I mutation</p><p>...
<p>Difference in the incidence of YMDD mutation between HBeAg positive and HBeAg negative patients.<...
<p>Mutation frequency (%): the ratio of total mutant clones to total aligned coverage at each nucleo...
<p>Prevalence of Precore, Core and Surface region mutations in HBV isolated among different clinical...
AbstractObjectiveThis study aimed to determine the natural prevalence of variants of tyrosinemethion...
<p>Individual HBV DNA level of the 3 patients with persist detectable DNA by RealT<i>ime</i>, but un...
Idue where variability was found in ARV-naïve patients. (N): number of samples from naïve patients h...
We sought to examine the role of hepatitis B virus (HBV) genotypes in virological breakthroughs and ...
DOI
Add to ORKG